The charts on this page feature a breakdown of the total annual pay for the top executives at GENMARK DIAGNOSTICS INC as reported in their proxy statements.

Total Cash Compensation information is comprised of yearly Base Pay and Bonuses. GENMARK DIAGNOSTICS INC income statements for executive base pay and bonus are filed yearly with the SEC in the edgar filing system. GENMARK DIAGNOSTICS INC annual reports of executive compensation and pay are most commonly found in the Def 14a documents.

Total Equity aggregates grant date fair value of stock and option awards and long term incentives granted during the fiscal year.

Other Compensation covers all compensation-like awards that don't fit in any of these other standard categories. Numbers reported do not include change in pension value and non-qualified deferred compensation earnings.

Name And Title Total Cash Equity Other Total Compensation
Hany Massarany
Former President and CEO
Total Cash $515,000 Equity $3,571,350 Other $2,352 Total Compensation $4,088,702
Scott Mendel
Former Chief Operating Officer; Former Chief Financial Officer; and current Interim President and CEO
Total Cash $505,347 Equity $1,242,700 Other $1,258 Total Compensation $1,749,305
Brian Mitchell
Senior Vice President, Operations
Total Cash $372,438 Equity $731,000 Other $2,352 Total Compensation $1,105,790
James McNally
Former Senior Vice President, Marketing and Business Development
Total Cash $409,882 Equity $986,850 Other $492 Total Compensation $1,397,224
Mike Gleeson
Senior Vice President, Corporate Accounts
Total Cash $394,346 Equity $731,000 Other $820 Total Compensation $1,126,166
Johnny Ek
Chief Financial Officer
Total Cash $397,831 Equity $731,000 Other $547 Total Compensation $1,129,378
For its 2019 fiscal year, GENMARK DIAGNOSTICS INC, listed the following CEO pay ratio data on its annual proxy statement to the SEC.
CEO Name CEO Pay Median Employee Pay CEO Pay Ratio
Hany Massarany CEO Pay $4,088,702 Median Employee Pay $61,695 CEO Pay Ratio 66:1
For its 2019 fiscal year, GENMARK DIAGNOSTICS INC, listed the following board members on its annual proxy statement to the SEC.
Name Total COMPENSATION
Daryl J. Faulkner Total Cash $156,402
James Fox, Ph.D. Total Cash $266,184
Kevin C. O¡_Boyle Total Cash $166,372
Lisa M. Giles Total Cash $157,855
Michael S. Kagnoff Total Cash $145,373

This report is not for commercial use. Thorough reviews have been conducted to assure this data accurately reflects disclosures. However for a complete and definitive understanding of the pay practices of any company, users should refer directly to the actual, complete proxy statement.

The information shown here is a reporting of information included in the company's proxy statement. The proxy statement includes footnotes and explanations of this information plus other information that is pertinent in assessing the overall value and appropriateness of the compensation information. For those interested in conducting a detailed compensation analysis, we recommend that you review the entire proxy statement. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov and entering the company's name and then looking in the first column for an entry of "Form DEF 14A" (or any similar code). You may also find the annual proxy statement by going directly to the company's website.

A proxy statement (or "proxy") is a form that every publicly traded U.S. company is required to file with the U.S. Securities & Exchange Commission (SEC) within 120 days after the end of its fiscal year. The proxy must be sent to every shareholder in advance of the company's annual shareholders meeting. All proxy statements are public filings made available to the general public by the SEC.

The proxy statement's main purpose is to alert shareholders to the annual meeting and provide them information about the issues that will be voted on during the annual meeting, including decisions such as electing directors, ratifying the selection of auditors, and other shareholder-related decisions, including shareholder-initiated initiatives. Also, proxies must disclose specific detailed information regarding the pay practices for certain executives.